v3.26.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating Activities:    
Net loss $ (20,410) $ (31,827)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 1,228 941
Impairment of long-lived assets 9,468
Allowance for credit loss 886 (111)
Allowance for inventory obsolescence and slow-moving inventory 41
Loss on disposition of subsidiary 132
Change in fair value of warrant liability (552) 22,123
Liability instrument issuance costs 189
Stock based compensation 9,006 3,429
Change in operating assets and liabilities:    
Accounts receivable (28) (224)
Inventory (1,118) (3)
Prepaid expenses and other current assets (1,126) (133)
Right-of-use asset 116 (289)
Other noncurrent assets (13)
Accounts payable (43) 187
Deferred revenue 140
Tax payable 24 35
Accrued expenses and other payables (1,219) (15)
Operating lease liabilities (100) 289
Net cash used in operating activities (3,568) (5,409)
Cash flows from investing activities:    
Purchase of property and equipment (21,749) (4,839)
Purchase of intangible assets (30) (84)
Purchase of short-term investments (68,273) (36,676)
Net cash effect of deconsolidation of subsidiary (3)
Proceeds from sale of long-term investments 193
Purchase of long-term investments (18) (142)
Proceeds from maturities and sales of short-term investments 96,848
Net cash provided by (used in) investing activities 6,968 (41,741)
Cash flows from financing activities:    
Payment of loans received from third parties (16) (53)
Loans received from third parties 22
Payments of tax withholdings for restricted stock awards (1,769)
Contributions from Non-controlling Interests 4
Proceeds from warrants exercise 9,812 18,038
Payment of issuance cost of ordinary shares (5,344) (1,180)
Proceeds from issuance of ordinary shares 110,301 48,650
Net cash provided by financing activities 112,988 65,477
Net change in cash and cash equivalents 116,388 18,327
Cash and cash equivalents at beginning of the period 185,574 14,566
Cash and cash equivalents at end of the period 301,962 32,893
Supplemental noncash disclosures:    
Intangible assets acquired in exchange for common shares 3,701
Reduction of ROU asset from partial termination 97
Reduction of lease liability from partial termination 104
Transfer of notes receivable in settlement for inventory purchases 523
Reclassification of warrant from mezzanine equity to permanent equity upon exercise $ 385